4-Hydrazinyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidine

Catalog No. :
ACFGLC952
CAS No. :
374611-25-3
Molecular Formula :
C13H12N4S
Molecular Weight :
256.33

IUPAC Name:4-hydrazineyl-5-(p-tolyl)thieno[2,3-d]pyrimidine

4-Hydrazinyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$101.00Login to see priceInquiryInquiry
100mg98%$141.00Login to see priceInquiryInquiry
250mg98%$195.00Login to see priceInquiryInquiry
1g98%$481.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Hydrazinyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidine
IUPAC Name4-hydrazineyl-5-(p-tolyl)thieno[2,3-d]pyrimidine
MDL No.MFCD01935058
Molecular FormulaC13H12N4S
Molecular Weight256.33
SMILESCC1=CC=C(C2=CSC3=NC=NC(NN)=C32)C=C1
InChI KeyAYKDFJSSVGWNPY-UHFFFAOYSA-N
SynonymThieno[2,3-d]pyrimidine, 4-hydrazinyl-5-(4-methylphenyl)-;4-Hydrazinyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidine
CAS No.374611-25-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFGLC952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRXF628 route compound structure diagram
    ACBRXF628374104-63-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFGLC952 route product structure diagram
    ACFGLC952374611-25-3
Inquiry

2. ACFGLC952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIANK506 route compound structure diagram
    ACIANK50617509-21-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFGLC952 route product structure diagram
    ACFGLC952374611-25-3
Inquiry

Comments (0)